70 related articles for article (PubMed ID: 10790317)
1. Development of an Aspergillus fumigatus cell-free protein synthesis assay.
Zamarro MT; Martín JJ; Domínguez JM
Anal Biochem; 2000 May; 280(2):320-2. PubMed ID: 10790317
[No Abstract] [Full Text] [Related]
2. Measurement of protein biosynthesis in Pneumocystis carinii to investigate the effects of translation-specific inhibitors.
Bishop RL; Jackson HC; Warhurst DC
J Eukaryot Microbiol; 1994; 41(5):76S-78S. PubMed ID: 7804274
[No Abstract] [Full Text] [Related]
3. Differential expression of Aspergillus fumigatus protein in response to treatment with a novel antifungal compound, diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarboxylate.
Chhillar AK; Yadav V; Kumar A; Kumar M; Parmar VS; Prasad A; Sharma GL
Mycoses; 2009 May; 52(3):223-7. PubMed ID: 18793265
[TBL] [Abstract][Full Text] [Related]
4. Screening method to identify inhibitors of siderophore biosynthesis in the opportunistic fungal pathogen, Aspergillus fumigatus.
Pinto LJ; Moore MM
Lett Appl Microbiol; 2009 Jul; 49(1):8-13. PubMed ID: 19453952
[TBL] [Abstract][Full Text] [Related]
5. Unique mechanism of action of an antifungal antibiotic RI-331.
Yamaki H; Yamaguchi M; Nishimura T; Shinoda T; Yamaguchi H
Drugs Exp Clin Res; 1988; 14(7):467-72. PubMed ID: 3071450
[TBL] [Abstract][Full Text] [Related]
6. Aspergillus fumigatus: cell wall polysaccharides, their biosynthesis and organization.
Gastebois A; Clavaud C; Aimanianda V; Latgé JP
Future Microbiol; 2009 Jun; 4(5):583-95. PubMed ID: 19492968
[TBL] [Abstract][Full Text] [Related]
7. Membrane and cell wall targets in Aspergillus fumigatus.
Beauvais A; Latgé JP
Drug Resist Updat; 2001 Feb; 4(1):38-49. PubMed ID: 11512152
[TBL] [Abstract][Full Text] [Related]
8. Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0.
Aruna K; Chakraborty T; Rao PN; Santos C; Ballesta JP; Sharma S
Gene; 2005 Aug; 357(1):9-17. PubMed ID: 16099608
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional proteome reference maps for the human pathogenic filamentous fungus Aspergillus fumigatus.
Vödisch M; Albrecht D; Lessing F; Schmidt AD; Winkler R; Guthke R; Brakhage AA; Kniemeyer O
Proteomics; 2009 Mar; 9(5):1407-15. PubMed ID: 19253289
[TBL] [Abstract][Full Text] [Related]
10. Identification of phoslactomycin E as a metabolite inducing hyphal morphological abnormalities in Aspergillus fumigatus IFO 5840.
Mizuhara N; Usuki Y; Ogita M; Fujita K; Kuroda M; Doe M; Iio H; Tanaka T
J Antibiot (Tokyo); 2007 Dec; 60(12):762-5. PubMed ID: 18277002
[TBL] [Abstract][Full Text] [Related]
11. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.
Garcia-Effron G; Mellado E; Gomez-Lopez A; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 May; 49(5):2119-21. PubMed ID: 15855543
[TBL] [Abstract][Full Text] [Related]
12. High-yields heterologous production of the novel Aspergillus fumigatus elastase inhibitor AFUEI in Aspergillus oryzae.
Yamashita N; Komori Y; Okumura Y; Uchiya K; Matsui T; Nishimura A; Ogawa K; Nikai T
J Biosci Bioeng; 2011 Aug; 112(2):114-7. PubMed ID: 21543256
[TBL] [Abstract][Full Text] [Related]
13. Targeting antioxidative signal transduction and stress response system: control of pathogenic Aspergillus with phenolics that inhibit mitochondrial function.
Kim JH; Campbell BC; Mahoney N; Chan KL; May GS
J Appl Microbiol; 2006 Jul; 101(1):181-9. PubMed ID: 16834605
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
[TBL] [Abstract][Full Text] [Related]
15. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.
Araujo R; Coutinho I; Espinel-Ingroff A
J Antimicrob Chemother; 2008 Dec; 62(6):1277-80. PubMed ID: 18824456
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of Candida species and Aspergillus fumigatus by statins.
Macreadie IG; Johnson G; Schlosser T; Macreadie PI
FEMS Microbiol Lett; 2006 Sep; 262(1):9-13. PubMed ID: 16907733
[TBL] [Abstract][Full Text] [Related]
17. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
Dannaoui E; Persat F; Borel E; Piens MA; Picot S
Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
19. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
Enserink M
Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
[No Abstract] [Full Text] [Related]
20. Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus.
Rodrigues AG; Araujo R; Pina-Vaz C
Int J Antimicrob Agents; 2006 Apr; 27(4):339-43. PubMed ID: 16527460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
